VPH.CN
Valeo Pharma Inc
Price:  
0.59 
CAD
Volume:  
98,600
Canada | Manufacturing

VPH.CN WACC - Weighted Average Cost of Capital

The WACC of Valeo Pharma Inc (VPH.CN) is 7.7%.

The Cost of Equity of Valeo Pharma Inc (VPH.CN) is 8.45%.
The Cost of Debt of Valeo Pharma Inc (VPH.CN) is 5.5%.

RangeSelected
Cost of equity6.8% - 10.1%8.45%
Tax rate26.5% - 26.5%26.5%
Cost of debt4.0% - 7.0%5.5%
WACC6.2% - 9.2%7.7%
WACC

VPH.CN WACC calculation

CategoryLowHigh
Long-term bond rate3.4%3.9%
Equity market risk premium4.7%5.7%
Adjusted beta0.740.99
Additional risk adjustments0.0%0.5%
Cost of equity6.8%10.1%
Tax rate26.5%26.5%
Debt/Equity ratio
0.20.2
Cost of debt4.0%7.0%
After-tax WACC6.2%9.2%
Selected WACC7.7%

VPH.CN's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for VPH.CN:

cost_of_equity (8.45%) = risk_free_rate (3.65%) + equity_risk_premium (5.20%) * adjusted_beta (0.74) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.